## Abstract ## BACKGROUND Vascular endothelial growth factor C (VEGF‐C) plays an important role in lymphangiogenesis and activates VEGF receptor 3 (VEGFR‐3). By contrast, lymphatic spread is an important prognostic factor in patients with nonsmall cell lung carcinoma (NSCLC). The objective of the
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma
✍ Scribed by Naoyo Nishida; Hirohisa Yano; Kan Komai; Takashi Nishida; Toshiharu Kamura; Masamichi Kojiro
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 424 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
BACKGROUND
The vascular endothelial growth factor (VEGF) family and VEGF receptors (VEGFR) play an essential role in the angiogenesis of both pathologic and nonpathologic conditions. However, the prognostic significance of VEGF and VEGFR expression in ovarian carcinoma is unclear.
METHODS
The tissue expression levels of VEGF‐A, VEGF‐C, VEGFR‐2, and VEGFR‐3 in 80 specimens of ovarian carcinoma were examined immnohistochemically. The results obtained were analyzed clinicopathologically.
RESULTS
VEGF‐A, VEGF‐C, VEGFR‐2, and VEGFR‐3 were expressed both in tumor cells and in adjacent endothelial cells of blood and lymph vessels. The tissue expressions of VEGF‐C and VEGFR‐2 were correlated significantly with tumor extension, including peritoneal metastases outside the pelvic cavity (P = 0.0010 and P = 0.0008, respectively), lymph node metastases (P = 0.0030 and P = 0.0018, respectively), and positive ascitic cytology (P = 0.025 and P = 0.0016, respectively). Conversely, there was no significant correlation between VEGF‐A and VEGFR‐3 expression and clinicopathologic features of ovarian carcinoma. Logistic regression analysis revealed that the expressions of VEGF‐C and VEGFR‐2 also were independent risk factors for peritoneal and lymph node metastases. Survival curves determined by the Kaplan–Meier method and in univariate analysis demonstrated that high expression levels of VEGF‐C and VEGFR‐2 were associated with the 5‐year survival rate. In multivariate analysis, high expression levels of VEGF‐C and VEGFR‐2 emerged as independent indicators for disease‐specific survival.
CONCLUSIONS
High tissue expression of VEGF‐C and VEGFR‐2 reflects the aggressiveness of the spread of tumor in ovarian carcinoma. Thus, both have predictive value for identifying high‐risk patients who have a poor prognosis. Cancer 2004. © 2004 American Cancer Society.
📜 SIMILAR VOLUMES
## Background: The modulation of immunologic activities relevant to cancer by behavioral factors, such as stress, depression, and social support, is well documented. however, associations of behavioral factors with cytokines involved in tumor angiogenesis have not been studied. vascular endothelial
## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (flt‐4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph
## Abstract ## Background Vascular endothelial growth factor (VEGF) expression seems to be associated with worse overall survival in patients with head and neck squamous cell carcinoma. The purposes of this study were to assess the prognostic values of the immunohistochemical expression of VEGF an